Perspective Therapeutics, Inc. CATX
0.75 USD -0.03 (-3.85%)
Regular-session close
0.75 0.00 -0.50%
After hours · Nov 20, 6:45 PM ET
0.7407 Day range 0.79
0.7538 52-week range 5.65
- YTD
- -72.59%
- 1 year
- -64.44%
Held by funds
56 US ETFs and mutual funds hold CATX · largest positions
- NJM 0.01% of fund $5.10M
- FSSNX 0.01% of fund $3.64M
- VTI 0.00% of fund $2.96M
- IWM 0.00% of fund $2.29M
- BDSKX 0.04% of fund $1.91M
- NAJ 0.01% of fund $1.88M
- FSMAX 0.00% of fund $1.14M
- VXF 0.00% of fund $1.14M
- IWN 0.01% of fund $838.92K
- VTWO 0.00% of fund $694.85K
- IBB 0.01% of fund $608.95K
- IJE 0.04% of fund $565.60K
- DFAS 0.00% of fund $502.70K
- FISVX 0.02% of fund $482.75K
- SCHA 0.00% of fund $399.90K
- VHT 0.00% of fund $324.63K
- IWC 0.02% of fund $272.90K
- DFMC 0.00% of fund $231.57K
- MDSKX 0.00% of fund $222.01K
- FZIPX 0.00% of fund $109.87K
Ownership
Held by insiders 20.46%
Held by institutions 81.43%
Float held by institutions 102.37%
Institutions 174
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 8.14% | 5,504,822 | 17.29M | Sep 29, 2024 |
| Janus Henderson Group PLC | 7.10% | 4,799,352 | 15.07M | Sep 29, 2024 |
| Blackrock Inc. | 5.98% | 4,039,974 | 12.69M | Sep 29, 2024 |
| Avidity Partners Management, LP | 5.10% | 3,444,002 | 10.81M | Sep 29, 2024 |
| Commodore Capital Lp | 4.96% | 3,350,000 | 10.52M | Sep 29, 2024 |
| Vanguard Group Inc | 4.55% | 3,076,941 | 9.66M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.50% | 1,692,046 | 5.31M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.06% | 1,393,938 | 4.38M | Oct 30, 2024 |
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 1.72% | 1,162,536 | 3.65M | Sep 29, 2024 |
| Fidelity Advisor Biotechnology Fund | 1.56% | 1,052,713 | 3.31M | Oct 30, 2024 |
| Janus Henderson Global Life Sciences Fund | 1.41% | 953,832 | 3.00M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.19% | 806,419 | 2.53M | Sep 29, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AUSTIN MARK JOHN | Chief Financial Officer | Conversion of Exercise of derivative security | Apr 22, 2024 | 84,030 |
| HENSON HEIDI | Director | Purchase | Dec 3, 2024 | 0 |
| HUNT JONATHAN ROBERT | Chief Financial Officer | Purchase | Nov 24, 2024 | 48,800 |
| LANTHEUS ALPHA THERAPY, LLC | Beneficial Owner of more than 10% of a Class of Security | Purchase | Mar 5, 2024 | 0 |
| PUHLMANN MARKUS | Officer | Purchase | Jan 23, 2024 | 1,375,420 |
| SPOOR JOHAN M | Chief Executive Officer | Purchase | Dec 3, 2024 | 55,257 |
